Utilization Management (UM) Changes
(Effective July 1, 2020)
Notices of prior authorization, quantity limits and step therapy changes
Certain states require OptumRx to communicate prior authorization changes before the effective date. The following July 1, 2020 flyers are sent to members to outline the drugs affected by prior authorization, quantity limits, and step therapy based on benefit plan designs. Please review each document for more details.
Please note: these changes may not reflect final P&T Committee determinations. These changes are specific to prescription drug benefits only, and do not reflect changes that may occur at the health plan level. Prescribers are strongly encouraged to check with the health plan for other changes that may occur.